(UroToday.com) In one of the first sessions of the 2021 International Kidney Cancer Symposium (IKCS): North America meeting focusing on multimodality perspectives on clinical trials, Dr. Lola Fashoyin-Aje presented on the critical issue of health equity in clinical trials.